Company Overview and News

 
History In The Making: Hope For The Best, Prepare For The Worst

2018-09-20 seekingalpha
Credit/yield-based models suggest a recession is coming soon. How soon? Nobody knows, but let's say before Trump may start his second term.
IWO DIA IWN IWM

12
Should IQ Chaikin U.S. Small Cap ETF (CSML) Be on Your Investing Radar?

2018-09-12 zacks
Looking for broad exposure to the Small Cap Blend segment of the US equity market? You should consider the IQ Chaikin U.S. Small Cap ETF (CSML - Free Report) , a passively managed exchange traded fund launched on 05/16/2017.
IJR REGI IJR FOSL IWM

 
Small-Cap ETF (SMMD) Hits New 52-Week High

2018-09-07 zacks
For investors seeking momentum, the iShares Russell 2500 ETF (SMMD - Free Report) is probably on radar. The fund just hit a 52-week high, and shares of SMMD are up roughly 39.2% from their 52-week low price of $35.09/share.
SMMD IWM

 
Small-Cap ETFs in Focus on Trade Woes, Solid Economic Data

2018-09-07 zacks
Strong economic fundamentals and the tax reform have given the small-cap space an edge over the large caps (see all Small Cap ETFs here). Revenues from domestic exposure account for 79.4% for the small-cap stocks on the Russell 2000, marking a substantial difference from the S&P’s 69.7%. As most of the revenues for the small-cap segment come from domestic operations, their business is protected from the global trade crisis.
IWO IJR LGNZZ LGND LGNYZ LGNXZ IJR IWN IJT IWM LGNDZ

 
My Current View Of The S&P 500 Index: September 2018

2018-09-03 seekingalpha
Three of the four markets I follow were positive in August and those positive gains translated into a nice return in my retirement account. The market, as measured by the S&P 500 index, closed 3.03% higher in August. As for my pension plan assets, I had a positive return in August as mentioned above and consequently my first investment objective, preservation of capital, was achieved with a 3.20% return on my assets.
AGG EFA IWM

9
Top ETF Stories of August

2018-08-31 zacks
Overruling the historical trend, the U.S. market has put up a good show so far in the month of August. In fact, a consensus carried out from 1950 to 2017 shows that August has offered positive stock returns in 37 years and negative in 31, per moneychimp.com, the average negative return being 0.27%.
ACWI STZ.B MJ TUR DIA STZ IWM CGC EWW DGE DGE DEO EEM

4
Will This Time Be Different? I Strongly Doubt That. So Should You!

2018-08-30 seekingalpha
Will this time be different? I strongly doubt that, but it can certainly move on like this for a while longer.
WFC WFCNP DIA IWN IWM MDY IWO

 
Small-Caps Rule in August: Top-Performing ETFs

2018-08-27 zacks
Overruling the historical trend, the U.S. market has put up a good show so far in the month of August. In fact, a consensus carried out from 1950 to 2017 shows that August has offered positive stock returns in 37 years and negative in 31, per moneychimp.com, the average negative return being 0.27%.
DIA IWM

11
Should IQ Chaikin U.S. Small Cap ETF (CSML) Be on Your Investing Radar?

2018-08-20 zacks
Launched on 05/16/2017, the IQ Chaikin U.S. Small Cap ETF (CSML - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Small Cap Blend segment of the US equity market.
JILL IJR IJR FOSL IWM ESND

1
U.S. Weekly FundFlows Insight Report: Trade-War Jitters Keep Equity Mutual Fund Investors At Bay During The Week

2018-08-10 seekingalpha
For the third consecutive week, investors were net purchasers of overall fund assets (including those of conventional funds and ETFs), injecting $20.5 billion for Thomson Reuters Lipper's fund-flows week ended August 8, 2018. But, despite continued strong corporate earnings and a fair nonfarm-payrolls report during the week, fund investors were net redeemers of equity funds (-$962 million), while they padded the coffers of money market funds (+$16.
IEF IEMG AAPL TIP IWM

1
My Current View Of The S&P 500 Index: August 2018

2018-08-01 seekingalpha - 1
The markets were very positive in July and those gains translated to a nice return in my retirement account. The market, as measured by the S&P 500 index, closed 3.60% higher in July. As for my pension plan assets, I had a positive return in July as mentioned above and consequently my first investment objective, preservation of capital, was achieved with a 3.15% return on my assets. My second investment objective, beating the S&P 500 index as measured by the ETF SPY, was not accomplished as SPY bested my return by 0.
AGG EFA IWM

1
ETF Asset Report of July

2018-07-31 zacks
Despite trade war and rising rate worries, the broader market remained steady in July, with the S&P 500-based ETF (SPY - Free Report) , Dow Jones-based ETF (DIA - Free Report) and Nasdaq 100-based (QQQ - Free Report) adding in the range of 1.3% to 4.2%. Still, the value quotient prevailed. Assets that are trading cheaper and offer safety appeared to have hauled in more money. Let’s delve a little deeper.
VTV SCHX UTX 2840 EFA IWM GLD

9
Top ETF Stories of July

2018-07-31 zacks
The month of July was all about trade, tech and corporate earnings. Trade war tensions seem to have peaked between the United States and China. U.S. tech stocks had a spectacular journey before falling after Jul 25 on acute pain in the social media and semiconductor space (read: Semiconductor ETFs to Tap Intel's Dip Post Q2 Earnings).
FB TWTR VGK UTX IWM

13
Should IQ Chaikin U.S. Small Cap ETF (CSML) Be on Your Investing Radar?

2018-07-27 zacks - 1
The IQ Chaikin U.S. Small Cap ETF (CSML - Free Report) was launched on 05/16/2017, and is a passively managed exchange traded fund designed to offer broad exposure to the Small Cap Blend segment of the US equity market.
JILL IJR IJR NVR TRN FOSL IWM ESND

 
U.S. Weekly FundFlows Insight Report: Despite Strong Earnings Reports During The Week, Fund Investors Remain Guarded In The Face Of Trade-War Concerns

2018-07-27 seekingalpha
For the second consecutive week investors were net purchasers of overall fund assets (including those of conventional funds and ETFs), injecting, however, only a little more than $13 million for Thomson Reuters Lipper's fund-flows week ended July 25, 2018. But, despite strong corporate earnings and economic news reported during the week, fund investors were net redeemers of equity funds (-$620 million) and money market funds (-$1.
BBJP IEF IWM

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to IWM / iShares Russell 2000 ETF on message board site Silicon Investor.

January Effect 2011 January Effect 2011 January Effect 2011 January Effect 2012 January Effect 2012 January Effect 2012
January Effect 2007 January Effect 2007 January Effect 2007 January Effect 2006 January Effect 2006 January Effect 2006
January Effect 2005 January Effect 2005 January Effect 2005
CUSIP: 464287655